L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3136
ETF rank
โ‚น2.16 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น1,422
Share price
-0.80%
Change (1 day)
36.22%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of August 2026: 0.49%